Kiniksa Pharmaceuticals International Plc (KNSA)
46.08
+0.45
(+0.99%)
USD |
NASDAQ |
Mar 20, 16:00
46.00
-0.08
(-0.17%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Research and Development Expense (Quarterly) : 34.49M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.141M |
| NovoCure Ltd. | 60.90M |
| LivaNova Plc | 51.50M |
| Aurinia Pharmaceuticals, Inc. | 10.90M |
| Alterola Biotech, Inc. | -- |